MedTrace Logo

Modality of Induction of Labor in Obese Women at Term (MODOBAT)

NCT04299854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2021-05-03

No results posted yet for this study

Summary

In normal-weight patients, numerous studies show an equivalence of efficacy between dinoprostone and balloon to induce labor. In obese patients, this efficacy is not known, although inductions of labor are more frequent. MODOBAT aims to describe the ability to obtain a vaginal delivery of two modality of induction of labor (vaginal dinoprostone and single balloon Foley catheter) in obese women at term.

Conditions

  • Induction of Labor Affected Fetus / Newborn
  • Obese

Interventions

DRUG

Dinoprostone 10mg

Vaginal delivery system containing 10mg of dinoprostone placed at the bottom of the vagina

DEVICE

single balloon Foley catheter

A single balloon Foley catheter is being inserted on transcervical and inflated above the internal cervical os

Sponsors & Collaborators

  • Hopital Nord Franche-Comte

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-11
Primary Completion
2020-12-12
Completion
2020-12-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04299854 on ClinicalTrials.gov